Bryan Johnson reveals incurable autoimmune gastritis diagnosis
Bryan Johnson, the 48-year-old millionaire biohacker who spends millions trying to reverse aging, has revealed he was diagnosed in May with autoimmune gastritis (AIG)—an incurable condition where the immune system attacks the stomach lining. Johnson told followers on X that his "stomach is eating itself," marking a serious setback in his quest to live forever.
The tech founder behind Project Blueprint, who reportedly spends nearly ₹20 crore annually on health and age-reversal therapies, shared the news in a lengthy social media post that has ricocheted across health and finance coverage. For a man whose brand is built on measurable biological age reversal, discovering a hidden autoimmune disease raises questions about whether even the most aggressive wellness spending can catch what standard medicine misses.
Key Takeaways
- Bryan Johnson revealed in May 2026 that he has autoimmune gastritis (AIG), a chronic condition where the immune system attacks the stomach lining.
- The disease affects an estimated 2–5% of people but is often silent and difficult to diagnose without specialized testing.
- AIG causes irreversible damage that can lead to nutritional deficiencies, anemia, and elevated long-term cancer risk.
- There is no approved cure; conventional treatment focuses on managing symptoms and correcting deficiencies.
- Johnson plans to pursue experimental therapies while monitoring key biomarkers including ferritin, B12, and gastrin.
What illness did Bryan Johnson reveal?
Johnson disclosed that he has autoimmune gastritis, writing on X: "I have an autoimmune disease. My stomach is eating itself." AIG occurs when the immune system attacks healthy acid-producing cells in the stomach lining, impairing digestion and nutrient absorption.
He was diagnosed in May after a bi-directional endoscopy, blood tests showing elevated anti-parietal cell antibodies, and stomach biopsies that confirmed early atrophy. His colonoscopy came back clear, ruling out hidden bleeding as the cause of his long-standing iron issues.
Why is autoimmune gastritis so hard to detect?
According to Johnson and medical reporting, AIG is "hard to detect, often silent"—a major reason it may affect far more than the estimated 2–5% of the population. For over 11 years, he had low ferritin levels without anemia, a pattern doctors repeatedly dismissed because his hemoglobin readings looked normal.
Johnson had managed hypothyroidism since age 21 with daily hormone replacement, unaware his stomach had begun attacking itself. The conditions are linked through thyrogastric syndrome, where thyroid and stomach autoimmunity reinforce one another and complicate treatment.
Can Bryan Johnson's condition be cured?
There is no approved cure for AIG. As Johnson noted, standard medical care "concedes defeat," focusing on symptom management rather than reversal. He received a 1,000 mg Monoferric iron infusion to correct his iron deficiency, but the underlying autoimmune damage is considered irreversible.
Johnson and his medical team intend to pursue experimental approaches—including advanced immune profiling and investigational therapies—while routinely monitoring ferritin, iron, B12, gastrin, and chromogranin A. He acknowledged that tiers of this plan remain preclinical and unproven.
What does this mean for his anti-aging quest?
The diagnosis is a stark reminder that wealth and vigilance do not guarantee immunity from hidden disease. Johnson, whose extreme net worth and wellness spending have made him a global symbol of biohacking, said had he not invested in his health over the past five years, his situation could be far more serious.
Medical experts describe autoimmune gastritis as a manageable but lifelong condition. Johnson's case is now being watched for whether experimental medicine can achieve what conventional care says is impossible. For authoritative background on gastritis, see the National Institute of Diabetes and Digestive and Kidney Diseases.